Drug Name: Tecvayli
Active Ingredient: teclistamab-cqyv
Indications: To treat relapsed or refractory multiple myeloma among adults who have received at least four specific lines of therapy
Approval Date: 10/25/2022
Company: Janssen Pharmaceutical Companies
Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761291s000lbl.pdf